We have studied the GH-dependent expression of cytochrome P-450IIC12 (P-450 155 ) mRNA and insulinlike growth factor-l (IGF-I) mRNA in primary adult rat hepatocytes. The GH receptor (GHR), being the common denominator for the GH response, was also studied. The respective mRNA levels were measured with specific solution hybridization assays. By investigating the effects of insulin, IGF-I, T 3 , and corticosterone, alone or in combinations, in the presence or absence of GH we concluded that GH is indeed the inducer of P-450 15/S mRNA and IGF-I mRNA. However, insulin and IGF-I exerted a 2-fold potentiation of the GH-induced expression of the P-450 15 £ and IGF-I mRNA species. No significant effect of insulin was observed on GHR mRNA expression, but a translational or posttranslational effect on GHR was seen, in that insulin increased the binding of GH to the cells 4-fold. Furthermore, T 3 caused a 9-fold increase in the GH-induced expression of IGF-I mRNA. These observations led us to postulate a possible mechanism of hormonal interplay between GH, thyroid hormone, and IGF-I in vivo, i.e. a thyroid hormone potentiation of the GH-induced IGF-I expression, which, in turn, leads to an increased GHR level and thereby a potentiation of the GHinduced expression of P-450 15/ j and, at least transiently, of IGF-I.
INTRODUCTION
The obligatory role of GH for maintenance of postnatal body growth in mammals is well known (1) . It has also become evident that GH exerts effects on the expression of a variety of hepatic proteins, ranging from hormone and growth factor receptors to secretory proteins and enzymes (2) . In the rat, the effects of GH on somatic growth and on some of the hepatic proteins are related to the sexually differentiated secretory pattern of GH. The GH secretory profile in male rats is characterized by high peaks every 3-4 h separated by intervening troughs, with low to undetectable levels, and in females by more frequent lower amplitude peaks and higher trough levels (3, 4) .
Among the enzymes in rat liver that are affected by GH are members of the cytochrome P-450 family, catalyzing the oxidation of a vast array of endogenous and exogenous compounds (5) . Particularly, GH has been implicated as an important regulator of the con- Regulation of P-450i 53 and IGF-I 1935 stitutive expression of several P-450 species belonging to the P-450IIC 1 subfamily (6) (7) (8) , but GH can also modulate the effects of inducers of other P-450 enzymes (9) (10) (11) . The constitutively expressed femalespecific P-450 15/3 enzyme (P450IIC12), catalyzing the 15/3-hydroxylation of 17/3-or 21-sulfoconjugated steroids (12) , is induced at a pretranslational level by the continuous presence of GH in serum, as is the case in the intact female rat and in hypophysectomized animals continuously treated with GH (13) . This effect of GH is potentiated by T 4 and possibly by glucocorticoids in hypophysectomized rats (8) . The mechanisms mediating these potentiating effects are largely unknown. However, in the intact animal, thyroid hormones are important for normal GH secretion (14) and also influence GH binding in the liver (15) . To gain a deeper insight into the mechanisms governing GH regulation of cytochrome P-450 enzymes, it is of importance to study hormonal interplays and to understand the mechanisms of action of each individual hormone.
Little is known about the mechanisms of GH action, and it has been believed for some time that all of its peripheral effects were mediated via an endocrine action of insulin-like growth factor-l (IGF-I or somatomedin-C) produced in the liver (16) . This original somatomedin hypothesis has been challenged, since direct effects of GH and local production of IGF-I have been shown in several GH-responsive tissues, such as adipose tissue and cartilage (17, 18) . A physiological role of IGF-I in the adult rat liver has so far not been demonstrated (19) . However, there is no doubt that IGF-I is produced in the liver in response to GH, an effect mainly exerted at the transcriptional level (20) . Furthermore, thyroid hormone has been shown to modulate GH induction of hepatic IGF-I (21) .
A direct effect of GH, not mediated via IGF-I, on P450i 5/ j induction is evident from experiments in primary hepatocytes in culture (22) . By culturing primary liver cells on a basement membrane matrix in a serum-free medium, the cells maintain their liver-characteristic phenotype and respond to various inducers of P-450 enzymes (23) . In this system, GH as the only hormone is sufficient to induce P-450 15/3 as well as IGF-I, whereas IGF-I addition to the medium is ineffective in inducing P-45O 1W .
Since this primary hepatocyte system is eminently suited for studies on GH mechanisms of action in general as well as for studies on cytochrome P-450 regulation we have used it to characterize the hormonal interplay of GH, insulin, IGF-I, and thyroid and glucocorticoid hormones in the regulation of IGF-I and P-450 15/3 expression. The GH receptor (GHR) plays a pivotal role in the GH responses. The GHR was recently cloned from rat liver (24) , and it has, therefore, also been possible to study receptor mRNA levels. In addition, we have adressed the question of whether GH exerts a stabilizing effect on P-450 15/3 and IGF-I mRNA, 1 Recommended nomenclature according to Nebert et al., DNA, 6:1-11, 1987. and also compared the dependence on on-going protein synthesis for the induction of these two GH-regulated mRNA species.
RESULTS
In a recent study we have shown that GH induces the mRNA and protein levels of cytochrome P-450 15/3 in primary adult rat hepatocytes maintained on Matrigel and that insulin appears to augment the GH-induced expression of P-450i 5/3 mRNA (22). Here we have confirmed this observation by measuring the mRNA level of P-450i 5/3 with a specific, quantitative, and sensitive solution hybridization assay (Fig. 1) . Furthermore, the potentiating effect of insulin could be substituted for by including IGF-I in the medium instead of insulin. Tenfold lower concentrations of insulin and IGF-I were found to potentiate the GH-induced expression of P-450 15/3 mRNA to the same extent (data not shown). No additive effect was observed for combined insulin and IGF-I addition to the medium, possibly indicating a common mechanistic pathway of insulin and IGF-I. Similarity, IGF-I mRNA expression in GH-treated cells was potentiated by the addition of insulin or IGF-I to the medium (Fig. 1) .
To investigate whether insulin affects the level of GHR in primary hepatocytes, receptor mRNA levels and binding of GH were measured at various time points of culture age in the presence or absence of insulin (Fig.  2) . During the first 48-h period of culture, induction of cytochrome P-450s is impaired (22, 23) , and this period of primary culture age is regarded as unresponsive and might serve as an adaptation period to the in vitro environment. Therefore, the first measurements were Freshly isolated hepatocytes were seeded in insulin-containing medium on dishes precoated with Matrigel. After 18 h of plating, medium was changed to a hormone-free medium. Between 42-66 h of culture age, cells were incubated in medium containing no hormone, insulin (i; 10~6 M), IGF-I (450 ng/ml), hGH (500 ng/ml), or combinations of these hormones. Samples of hepatocyte tNA were prepared and analyzed in solution hybridization assays specific for P-450 15fl mRNA (•) and IGF-I mRNA (H), respectively. performed at 42 h of culture age, i.e. at the end of the unresponsive period. As shown in Fig. 2A , the GHR mRNA levels increased with time up to 66 h of culture age in both the presence and absence of insulin. Also, GH binding to the primary hepatocytes was increased with time, but in contrast to the receptor mRNA levels, it was strikingly dependent on the presence of insulin (Fig. 2B) . GH in the presence of insulin did not appear to be a major regulator of the GHR mRNA levels ( Fig.  2A) .
Even with the low binding of GH to the cells in the absence of insulin, a time course of induction of P-450 15/3 mRNA and IGF-I mRNA by GH could be achieved (Fig. 3) . However, when the cells were exposed to GH for more than 24 h, IGF-I mRNA accumulation ceased. The cRNA probe used to measure GHR mRNA levels is complementary to a sequence in the extracellular domain of the receptor which is identical to the sequence of the GH-binding protein (GHBP) found in serum (25) . In rodents, the GHBP has been suggested to be produced as the result of alternative splicing of the primary GHR transcript (26) . Thus, both the receptor mRNA and the binding protein mRNA may contribute to the levels determined with the solution hybridization assay. During the course of this study, solution hybridization assays specific for the receptor and the binding protein, respectively, were developed. Indeed, both mRNA species were detected. The ratio of GHR mRNA/ GHBP mRNA was not significantly different between control cells (1.25 ± 0.31) and GH-treated cells (1.26 ± 0.14), indicating that GH does not regulate the splicing preference under these conditions. The given ratios are the mean ± SD from three separate experiments.
The increased expression of GHR mRNA levels between 42-66 h of culture age and the increased ligand binding in the presence of insulin led us to perform the subsequent studies on GH effects on P-450i 5/3 mRNA and IGF-I mRNA levels at time points greater than 66 h of culture age and in the presence of insulin. In vivo experiments in hypophysectomized animals have shown that T 4 and possibly glucocorticoids have a potentiating effect on the GH induction of P-450 15/3 mRNA accumulation (8) . However, neither thyroid nor glucocorticoid hormones exerted any potentiating effect of GH on the P-450 15/3 mRNA accumulation in the primary hepatocytes (Fig. 4) . On the contrary, glucocorticoids appeared to reduce the GH effect on P-450 15/S and IGF-I mRNA accumulation. This inhibitory effect of glucocorticoids is most likely exerted via an effect on GH receptor expression, since the GHR mRNA level was reduced in cultures containing corticosterone ( Cells were seeded and maintained in the presence of insulin throughout the experiment. At 66 h of culture age, cells were incubated with hGH (500 ng/ml), T 3 (10~9 M), corticosterone (C; 10" 9 M), or combinations of these hormones. Cells were harvested 24 h later, and tNA samples were analyzed for P-450i 5/S (•), IGF-I P ) , and GHR (•) mRNA contents, n.d., Not detectable. 4 ). However, the inhibitory effects of glucocorticoids were abolished in the presence of T 3 . Furthermore, T 3 potentiated the GH-stimulated induction of IGF-I mRNA levels (Fig. 4) .
To address the question of whether GH alters P-450 1S/3 mRNA stability, primary hepatocytes were treated with GH to induce the message and thereafter treated with actinomycin-D in the presence or absence of GH. No effect of GH on the stability of the P-450i 5/3 mRNA could be seen (Fig. 5A) , and GH did not alter the stability of the IGF-I mRNA (Fig. 5B) . From the decay curves, half-lives of 10 and 15 h were calculated for P-450 15/s and IGF-I mRNAs, respectively. Two-fold longer half-lives were found after withdrawal of GH without inhibition of transcription (Fig. 5) .
The effects of protein synthesis inhibition on the GH induction of P-450 15/3 mRNA and IGF-I mRNA were compared. Cycloheximide completely abolished the induction of P-45Oi 5 0 mRNA (Fig. 6A) , whereas IGF-I mRNA induction was not affected (Fig. 6B) . Cycloheximide alone had no effect on P-450 15/3 or IGF-I mRNA levels, and furthermore, after withdrawal of cycloheximide, the induction of P-450i 5/3 by GH was restored (data not shown).
DISCUSSION
Studies of molecular mechanisms of liver functions and their regulation have in many cases been hampered by the lack of a suitable liver cell culture system. A better understanding of the importance of cell-cell and cellsubstratum interactions for the maintenance of cell differentiation and phenotype characteristics in vitro has recently resulted in a culture system for primary rat hepatocytes that permits expression of numerous liverspecific genes (23, 27) . Hepatocytes maintained on the basement membrane matrix, Matrigel, and in a minimal serum-free medium respond to various inducers and/or repressors of specific cytochrome P-450 enzymes (22, 23, 28) . This system has been used to conclusively confirm that GH is the major inducer of the femalespecific cytochrome P-450 15/3 in rat liver (22) . IGF-I synthesis is also mainly under the control of GH (29) and is induced by GH in this primary hepatocyte system (22) .
Our earlier study, suggesting that insulin augments P-450i5,j mRNA expression in primary hepatocytes in response to GH (22) , is confirmed by our present results. The potentiating effect of insulin on GH-induced IGF-I mRNA expression led us to investigate the effect of insulin on the GHR, it being an obvious common denominator for the GH effects on these two genes. Although culture age seems to be a more important factor for the accumulation of GHR mRNA levels than insulin, a significant effect of insulin is observed on binding of GH in the primary hepatocytes at all time points studied (Fig 2) . These data correlate to results obtained from animal experiments, showing a reduction of somatogenic receptors (30) , but no significant effect on the receptor mRNA level (31), in experimental diabetes. Thus, it is possible to suggest that insulin stimulates the translation or posttranslational processing of GHR in primary hepatocytes. Our finding that insulin influences the GH-induced accumulation of IGF-I mRNA is at variance with results from primary hepatocyte experiments presented by Johnson et al. (32) . In their cell culture system the cells were apparently maintained directly on the plastic dishes, and furthermore, their serum-free medium contained T 4 and hydrocortisone. Together, these differences might be responsible for this discrepancy.
In a previous study from our laboratory it was clearly shown that T 4 of continuous GH administration to hypophysectomized rats (8) . In the primary hepatocytes, corticosterone had a negative effect on the induction of P-450i 5/9 mRNA by GH. This might be a dose-dependent discrepancy. As indicated by our results, a negative effect of glucocorticoids on GH responses could possibly be explained by effects on GHR mRNA levels, which were reduced by corticosterone in the primary hepatocytes.
The lack of potentiating effect of thyroid hormone on GH induction of P-450 15/3 mRNA in vitro is in contrast to our in vivo findings (8) . However, GH-induced expression of IGF-I mRNA was increased by T 3 , which is in agreement with in vivo experiments presented by Wolf et al. (21) . IGF-I or insulin per se have no effect on P-450 15/3 expression either in vivo in hypophysectomized animals (our unpublished data) or in vitro as shown here, but potentiate the GH effect. Their respective, but nonadditive, capacity to potentiate the GH response may indicate a common mechanism of action. Therefore, a potentiating effect of T 3 on the GH effect via Cells were seeded and maintained in the presence of insulin throughout the experiment. The medium change at 66 h of culture age involved addition of hGH (500 ng/ml; • ) , hGH (500 ng/ml) plus cycloheximide (1 ^g/ml; ^) , cycloheximide (1 ng/ ml; B), or no addition (•). Cultures were harvested 4 and 9 h later. Prepared tNA samples were analyzed for P-450 15^ mRNA and IGF-I mRNA contents.
increased IGF-I expression might be masked in cell cultures maintained in insulin-containing medium. Taken together, one may hypothezise that thyroid hormone potentiates the GH-induced expression of IGF-I, which, in turn, may lead to an increased GHR level and, thereby, a potentiation of GH-induced P-450 15/9 expression. Also, binding of GH to liver membranes has been shown to be directly related to the thyroid status of the animal (15) . Contradictory to the suggestion of an autocrine and/or paracrine effect of IGF-I in the liver is the fact that adult rat hepatocytes possess very low or undetectable IGF-I receptor levels (33, 34) . Although binding preferentially occurs to the homologous receptor, cross-reactivity between IGF-I and insulin and their receptors has been shown (35, 36) . Thus, it is possible that IGF-I potentiation of the GH response could be mediated via either of these receptors.
No major effect on the GHR mRNA level by GH was observed in the primary hepatocytes, a finding supported by the fact that livers of hypophysectomized and intact adult rats express equivalent amounts of receptor mRNA (24) . However, the increased expres-sion of IGF-I in response to GH might stimulate translation or posttranslational processing of the GHR in an analogy to the insulin effect observed in this study (see above). This could explain the reported GH stimulatory effect on GH binding (37) . Due to alternative splicing of the primary GH receptor transcript, mRNA species corresponding to both the receptor and the serum binding protein (GHBP) are produced (38) . The function of the GHBP is unclear. Several reports have shown that the half-life of GH is prolonged by the binding protein and that it competes with cellular receptors and reduces the ability of GH to give rise to its biological activity (39, 40) . Furthermore, a tissue-specific splicing preference has been indicated which would determine GHR/GHBP ratios (41) . Using a probe detecting both mRNA species in attempts to measure GHR mRNA levels could lead to an incorrect conclusion regarding its dependence on GH. Indeed, both transcripts are present in the primary hepatocytes, but no splicing preference as a result of GH exposure could be detected. Our measurements, therefore, represent receptor levels, even though at overestimated levels.
It is of considerable interest to study the mechanisms by which GH exerts its effects on P-450 induction in the liver, since the expression of several P-450s is either constitutively regulated by GH or is modulated by GH when induced by xenobiotics (2, 6-11). GH does not seem to exert a stabilizing effect on P-450 15/3 mRNA in primary hepatocytes, although such an indication was obtained in previous in vivo experiments (42) . The same half-life of the IGF-I mRNA in actinomycin-D-treated cells in the presence and absence of GH indicates a transcriptional regulation of this gene, which is in agreement with the report of Mathews et al. (20) . The notion that the degradation time of both P-450i 5/3 and IGF-I mRNA is twice as long in the absence of transcriptional inhibition could reflect a reduced viability in the actinomycin-D-treated cells. Trypan blue exclusion was similar to that of untreated cells; nevertheless, inhibition of transcription for this length of time most likely affects the cell status. Another possibility for this discrepancy is that the Matrigel, on which the primary cells are maintained, retained GH, although the cultures were extensively washed to remove the hormone (see Fig.  5 ). However, the observed turnover of P-450 15^ mRNA is of the same magnitude as that for some P-450s in the adrenals, determined by pulse-chase experiments (43) .
The regulation by GH of P-450i 5/3 and IGF-I in liver and primary hepatocytes is similar inasmuch as they are induced by GH, but differences are also apparent. In hypophysectomized rats, a continuous administration of GH, mimicking the female GH secretory profile, induces both P-450 15/3 (8) and IGF-I (44, 45) . In contrast, an intermittent administration of GH, mimicking the male GH secretory pattern, is essentially ineffective in inducing P-450i 5/3 (8) , but is slightly more effective than continuous administration in inducing IGF-I (45). In the primary hepatocytes thyroid hormone potentiates GH induction of IGF-I mRNA, but not the induction of P-450 15/3 mRNA, an observation that certainly can be related to the fact that two completely different genes were studied, but may also be due to a difference in the GH signalling mechanisms. Most notable is the difference in cycloheximide sensitivity to the GH response. Here we can show an absolute requirement of on-going protein synthesis for the GH induction of P-450 15/3 mRNA, whereas the induction of IGF-I mRNA was found to be unaffected in the same experiments. At least a part of the inhibitory effect of cycloheximide on P-450 15/3 mRNA induction is most likely explained by a decreased number of GH receptors at the cell membrane, since the reported turnover of the GH receptor is approximately 30-40 min in rat liver (46) . Although only one cDNA encoding a GH receptor has been isolated so far, different subpopulations of GH receptors appear to exist, as revealed from epitope mapping studies (47) , and it is not inconceivable that different subclasses of receptors could show a different cycloheximide sensitivity.
The observed cessation of IGF-I mRNA induction after prolonged GH treatment in the absence of insulin is also notable and is in contrast to the P-45Oi 50 mRNA induction (Fig. 3) . This may relate to refractory phases to GH, which have been demonstrated for GH-stimulated protein synthesis in rat diaphragm muscle (48) . Furthermore, evidence has been provided for a role of proteins synthesized in response to GH in the maintenance of the refractory phase (49) . Whether that has any correlation to the insensitivity to cycloheximide of GH-induced IGF-I mRNA accumulation remains to be elucidated.
MATERIALS AND METHODS

Animals and Materials
Adult male Sprague-Dawley rats (Alab, Stockholm, Sweden), about 8 weeks of age, were maintained under standardized conditions of light and temperature, with free access to animal chow and water. Collagenase (type IV) was purchased from Sigma Chemical Co. (St. Louis, MO). Recombinant human GH (hGH; 2 U/mg) and recombinant IGF-I were generous gifts from Kabi AB (Stockholm, Sweden). T 3l corticosterone, insulin (24.4 U/mg), actinomycin-D, and cycloheximide were purchased from Sigma Chemical Co.. Proteinase-K was obtained from Merck (Darmstadt, Germany). Glass-fiber filters (Whatman GF/C, Clifton, NJ) were obtained from Whatman Ltd. (Maidstone, Kent, United Kingdom). RNase-A and RNase-T, were purchased from Boehringer-Mannheim (Mannheim, Germany). Reagents for in vitro transcription of cRNA probes were obtained from Promega Biotech (Madison, Wl).
Hepatocyte Isolation and Cell Culture
Matrigel was prepared from Engelbreth-Holm-Swarm sarcoma propagated in C57BL/6 female mice and stored at -2 0 C, as described previously (23) . After thawing on ice, 100-200 ^l were evenly innoculated onto 60-mm plastic dishes and allowed to form a gel at room temperature before cell isolation. Hepatocytes were prepared by nonrecirculating collagenase perfusion through the portal vein of ether-anesthetized rats according to the method of Bissell and Guzelian (50) . Cells VoUNo. 12 were seeded at a density of 3.5 x 10 6 /dish in 3 ml of a standard serum-free medium (50) . This medium is a modification of Waymouth's medium 752 containing amino acids, salts, vitamins, minerals (zinc, selenium), and, unless otherwise indicated, insulin (10" 6 M). Cultures were maintained in a humified incubator at 37 C in an atmosphere containing 5% CO 2 . All cultures were seeded in insulin-containing medium; 18-20 h later the medium was renewed and, where indicated, insulin was omitted. Thereafter, the medium was renewed daily.
Hormones and other additions were added in medium after passage through a 0.45-Mm filter. The concentrations of hormones were: hGH, 500 ng/ml; IGF-I, 450 ng/ml; T 3 , 10~9 M; and corticosterone, 10~8 M. Actinomycin-D was added at a concentration of 10 iug/ml, which inhibited [ 3 H]uridine incorporation into trichloroacetic acid-precipitable nucleic acids to 90% or more without significant effects on cell viability. Cycloheximide was added at a concentration of 1 /ug/ml, which inhibited [ 3 H]leucine incorporation into trichloroacetic acid-precipitable proteins to 90% or more without significant effects on cell viability.
At harvesting of cells, the medium was aspirated from the plates, and cells were washed and scraped with a rubber spatula in PBS and pelleted at 750 x g.
Solution Hybridization
Total nucleic acids (tNA) were prepared from the pooled cells from five to seven culture dishes by lysis of the cells in 1 % (wt/vol) sodium dodecyl sulfate (SDS), 10 ITIM EDTA, and 20 mM Tris-HCI, pH 7.5. Digestion of samples with proteinase-K and subsequent extraction with chloroform and phenol have been described previously (51) . The concentration of nucleic acids in tNA samples was measured spectrometrically, and the DNA concentration was quantified using a fluorometric assay (52) . Levels of P-45O 1W mRNA, IGF-I mRNA, and GHR mRNA were analyzed using [ , and GHR (24) have prevoiusly been described. To specifically determine the contribution of receptor and binding protein mRNA in the GHR assay, specific GHR mRNA was detected by a 120-basepair (bp) cRNA probe derived from a 170-bp BamH\-Pvu\\ fragment of the intracellular domain of the cloned rat GHR cDNA (24) , subcloned into pT7T318U (Pharmacia, Uppsala, Sweden). The GHBP mRNA was specifically detected by a 46-bp cRNA probe coding for the BP hydrophilic tail not found in the GHR cDNA (38) . To obtain this probe, synthetic oligonucleotides were annealed and cloned into pT7T318U. After sequencing of plasmid inserts, optimal assay conditions regarding temperature and formamide concentration were established and found to be the same as those in the GHR assay (24) . Briefly, hybridization of aliquots of tNA samples was performed in 40 //I 0.6 M NaCI, 22 mM Tris-HCI (pH 7.5), 5 mM EDTA, 0.1% (wt/vol) SDS, 1 mM dithiothreitol, formamide (probe-dependent concentration), and 15,000-20,000 cpm probe/incubation. After overnight incubation (probe-dependent temperature), the samples were exposed to RNases, and the hybrids were precipitated by the addition of 100 /il 6 M trichloroacetic acid, collected on a glass-fiber filter, and counted in a liquid scintillation counter.
Quantitation was achieved by comparison with a standard curve obtained from hybridizations to liver tNA. This liver tNA standard was calibrated to a standard curve using known amounts of in vitro synthesized mRNA. Samples were analyzed in triplicate, and the results are expressed as attomoles of mRNA per ^g DNA. The interassay variations averaged 10%.
All experiments were performed at least twice, with cells obtained from different rats. Each figure shows a representative experiment. . Binding studies were performed in triplicate directly in the culture dishes. Before the addition of radioactive tracer, the cultures were rinsed once in medium and preincubated with 3 ml PB (PBS supplemented with 0.1% BSA and 1 % serum from hypophysectomized rats) for 20 min at 21 C. Incubation of the cultures with 10 ng/ml 1Z5 l-labeled hGH (200,000 cpm) supplemented with 2 /*g/ml ovine PRL to compete out tracer binding to lactogenic receptor sites was performed in 1 ml PB for 3 h at 21 C in the presence or absence of unlabeled hGH (10 ng/m\). The incubation was terminated by washing the cells three times in PB on ice over a period of 20 min. Cells were scraped in 1% (wt/vol) SDS-0.1 M NaOH, and the radioactivity was counted in a 7-counter. Specific binding was calculated as the difference between binding in the absence or presence of unlabeled hGH (10 tig/ ml); nonspecific binding averaged 2%.
